Islet cell autoantibodies in African patients with Type 1 and Type 2 diabetes in Dar es Salaam Tanzania: a cross sectional study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Landin-Olsson M, Palmer JP, Lernmarks , Blom L, Sundkvist G, Nyström L, Dahlquist G: Predictive value of islet cell and insulin autoantibodies for Type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children. Diabetologia. 1992, V35: 1068-1073. 10.1007/BF02221683.
Notkins AL, Lernmark A: Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest. 2001, 108: 1247-1252. 10.1172/JCI200114257.
Akamine H, Komiya I, Shimabukuro T, Asawa T, Tanaka H, Yagi N, Taira T, Nagata K, Arakaki K, Wakugami T, Takasu N, Powell MJ, Furmaniak J, Smith BR: High prevalence of GAD65 (and IA-2) antibodies in Japanese IDDM patients by a new immunoprecipitation assay based on recombinant human GAD65. Diabet Med. 1997, 14: 778-784. 10.1002/(SICI)1096-9136(199709)14:9<778::AID-DIA461>3.0.CO;2-7.
Kawasaki E, Eguchi K: Is Type 1 diabetes in the Japanese population the same as among Caucasians?. Ann N Y Acad Sci. 2004, 1037: 96-103. 10.1196/annals.1337.014.
Kobayashi T, Sawano S, Itoh T, Sugimoto T, Tanaka T, Suwa S: The prevalence of islet-cell antibodies and complement-fixing islet-cell antibodies in Japanese diabetics. Endocrinol Jpn. 1981, 28: 429-433.
Lee YS, Ng WY, Thai AC, Lui KF, Loke KY: Prevalence of ICA and GAD antibodies at initial presentation of type 1 diabetes mellitus in Singapore children. J Pediatr Endocrinol Metab. 2001, 14: 767-772.
Todd AL, Ng WY, Lui KF, Thai AC: Low prevalence of autoimmune diabetes markers in a mixed ethnic population of Singaporean diabetics. Intern Med J. 2004, 34: 24-30. 10.1111/j.1444-0903.2004.00482.x.
McLarty DG, Athaide I, Bottazzo GF, Swai AM, Alberti KG: Islet cell antibodies are not specifically associated with insulin-dependent diabetes in Tanzanian Africans. Diabetes Res Clin Pract. 1990, 9: 219-224. 10.1016/0168-8227(90)90048-X.
Oli JM, Bottazzo GF, Doniach D: Islet cell antibodies and diabetes in Nigerians. Trop Geogr Med. 1981, 33: 161-164.
Omar MA, Bottazzo GF, Doniach D: Islet cell antibodies and other autoantibodies in South African blacks and Indians with insulin dependent diabetes mellitus (IDDM). Horm Metab Res. 1986, 18: 126-128.
Peters WH, Lester FT, Kohnert KD, Hildmann W: The frequency of islet cell surface antibodies in newly diagnosed diabetics from Ethiopia. Exp Clin Endocrinol. 1986, 87: 326-332.
Panz VR, Kalk WJ, Zouvanis M, Joffe BI: Distribution of autoantibodies to glutamic acid decarboxylase across the spectrum of diabetes mellitus seen in South Africa. Diabet Med. 2000, 17: 524-527. 10.1046/j.1464-5491.2000.00324.x.
Neufeld M, Maclaren NK, Riley WJ, Lezotte D, McLaughlin JV, Silverstein J, Rosenbloom AL: Islet cell and other organ-specific antibodies in U.S. Caucasians and Blacks with insulin-dependent diabetes mellitus. Diabetes. 1980, 29: 589-592. 10.2337/diabetes.29.8.589.
Libman IM, Pietropaolo M, Trucco M, Dorman JS, LaPorte RE, Becker D: Islet cell autoimmunity in white and black children and adolescents with IDDM. Diabetes Care. 1998, 21: 1824-1827. 10.2337/diacare.21.11.1824.
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997, 20: 1183-1197.
Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15: 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.
Pihoker C, Gilliam LK, Hampe CS, Lernmark A: Autoantibodies in diabetes. Diabetes. 2005, 54 Suppl 2: S52-61. 10.2337/diabetes.54.suppl_2.S52.
Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R: UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet. 1997, 350: 1288-1293. 10.1016/S0140-6736(97)03062-6.
Hiar CE: Clinical summary report. Clinical performance of DCA 2000+ hemoglobin A1c system six-minute assay. Bayer Diagnostic Division 1-7, April. 1998
The Diabetes Research in Children Network (DirectNet) Study Group. Comparison of fingerstick hemoglobin A1c levels assayed by DCA2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirectNet) Study. Pediatric Diabetes. 2005, 6: 13-16. 10.1111/j.1399-543X.2005.00088.x.
Bingley PJ, Bonifacio E, Mueller PW: Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes. 2003, 52: 1128-1136. 10.2337/diabetes.52.5.1128.
Pfutzner A, Harzer O, Kunt T, Forst T, Abdollahnia N, Lobig M, Krauss H, Engelbach M, Kann P, Beyer J: Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitus. Clin Lab. 2000, 46: 275-279.
Jaeger C, Hatziagelaki E, Petzoldt R, Bretzel RG: Comparative analysis of organ-specific autoantibodies and celiac disease--associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects. Diabetes Care. 2001, 24: 27-32. 10.2337/diacare.24.1.27.
Raile K, Noelle V, Landgraf R, Schwarz HP: Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes. 2001, 109: 393-396. 10.1055/s-2001-18991.
Fajardo C, Pinon F, Carmona E, Sanchez-Cuenca JM, Merino JF, Carles C: Influence of age on clinical and immunological characteristics of newly diagnosed type 1 diabetic patients. Acta Diabetol. 2001, 38: 31-36. 10.1007/s005920170026.
Damanhouri LH, Dromey JA, Christie MR, Nasrat HA, Ardawi MS, Robins RA, Todd I: Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients. Diabet Med. 2005, 22: 448-452. 10.1111/j.1464-5491.2005.01438.x.
Yih-Hsin Chang MYS: Autoantibodies against IA2, GAD, and topoisomerase II in type 1 diabetic patients. Biochemical and Biophysical research communications. 2004, 320: 802-809. 10.1016/j.bbrc.2004.05.215.
Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA: Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes. 1997, 46: 1701-1710. 10.2337/diabetes.46.11.1701.
Borg H, Arnqvist HJ, Bjork E, Bolinder J, Eriksson JW, Nystrom L, Jeppsson JO, Sundkvist G: Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS). Diabetologia. 2003, 46: 173-181. 10.1007/s00125-002-1021-4.
Decochez K, Tits J, Coolens JL, Van Gaal L, Krzentowski G, Winnock F, Anckaert E, Weets I, Pipeleers DG, Gorus FK: High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care. 2000, 23: 838-844. 10.2337/diacare.23.6.838.
Ota T, Takamura T, Nagai Y, Bando Y, Usuda R: Significance of IA-2 antibody in Japanese type 1 diabetes: its association with GAD antibody. Diabetes Res Clin Pract. 2005, 67: 63-69. 10.1016/j.diabres.2004.05.004.
Familial risk of type I diabetes in European children. The Eurodiab Ace Study Group and The Eurodiab Ace Substudy 2 Study Group. Diabetologia. 1998, 41: 1151-1156. 10.1007/s001250051044.
Altobelli E, Chiarelli F, Valenti M, Verrotti A, Blasetti A, Di Orio F: Family history and risk of insulin-dependent diabetes mellitus: a population-based case-control study. Acta Diabetol. 1998, 35: 57-60. 10.1007/s005920050102.
Sia C, Michael W: The Role of HLA Class I Gene Variation in Autoimmune Diabetes. Rev Diabet Stud. 2005, 2: 97-109. 10.1900/RDS.2005.2.97.